Next report date
Report period
Q1 2024
EPS estimate
5.29EUR
Revenue estimate
574.90 MEUR
19.1EUR
892.24 MEUR
2.11 BEUR
43.37 M
About United Therapeutics Corporation
Sector
CEO
Martine A. Rothblatt
Headquarters
Silver Spring
Website
Employees (FY)
1.17 K
Founded
1996
FIGI
BBG00CL72S82
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where UTH is featured.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange UTD THERAP. (DEL.) DL-,01 stocks are traded under the ticker UTH.
UTD THERAP. (DEL.) DL-,01 is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
UTH earnings for the last quarter are 5.09 EUR per share, whereas the estimation was 4.83 EUR resulting in a 5.45% surprise. The estimated earnings for the next quarter are 3.88 EUR per share. See more details about UTD THERAP. (DEL.) DL-,01 earnings.
UTD THERAP. (DEL.) DL-,01 revenue for the last quarter amounts to 576.49 M EUR despite the estimated figure of 554.18 M EUR. In the next quarter revenue is expected to reach 520.96 M EUR.
Yes, you can track UTD THERAP. (DEL.) DL-,01 financials in yearly and quarterly reports right on TradingView.
UTH net income for the last quarter is 196.69 M EUR, while the quarter before that showed 253.15 M EUR of net income which accounts for −22.30% change. Track more UTD THERAP. (DEL.) DL-,01 financial stats to get the full picture.
No, UTH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, UTH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UTD THERAP. (DEL.) DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 1.17 K employees. See our rating of the largest employees — is UTD THERAP. (DEL.) DL-,01 on this list?
We've gathered analysts' opinions on UTD THERAP. (DEL.) DL-,01 future price: according to them, UTH price has a max estimate of 346.07 EUR and a min estimate of 168.88 EUR. Read a more detailed UTD THERAP. (DEL.) DL-,01 forecast: see what analysts think of UTD THERAP. (DEL.) DL-,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. UTD THERAP. (DEL.) DL-,01 EBITDA is 1.12 B EUR, and current EBITDA margin is 53.35%. See more stats in UTD THERAP. (DEL.) DL-,01 financial statements.